Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines

Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines

US Patent 6869793 · Granted Mar 22, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immuno-modulated replication-efficient Vaccinia virus strain2025
Immuno-modulated replication-efficient vaccinia virus strain2023
Method for producing virus like particles2021
Antibodies specific for enteroviruses that infect humans2020
Antigens and vaccines directed against human enteroviruses2020
Antigens and vaccines directed against human enteroviruses2020
Antibodies specific for enteroviruses that infect humans2018
Antigens and vaccines directed against human enteroviruses2018
Flavivirus NS1 subunit vaccine2014
Recombinant MVA virus and the use thereof2012
Recombinant MVA virus and the use thereof2012
Recombinant MVA virus2012